George Petrocheilos

Co-Founder & Managing Partner of @CatalioCapital, a multi-strategy investment firm focusing on disruptive biomedical tech companies

[Catalio Capital Management @CatalioCapital]

Thank you to @BiotechTV and @cngarabedian of Perceptive for hosting Catalio's Co-Founder & Managing Partner, George Petrocheilos (@georgecpetro), on their most recent episode of the BioVenture VoiCes podcast.

Please tune in to listen to George discuss the Catalio journey:

[Chris Garabedian @cngarabedian]

Listen to Episode 45 of @BioVentureVoiCe video podcast w/ George Petrocheilos @georgecpetro, Co-Founder and Managing Partner at @CatalioCapital. George discusses how he moved Catalio into one of the top 5 most active VC investors since its founding in 2020, including recent M&A and IPO success in 2026. The full video is here on @BiotechTV (and also on Spotify and Apple Podcasts): https://t.co/BQnPv1qGoa

[Catalio Capital Management @CatalioCapital]

We are proud to be included on @TIME’s list of America’s Top Venture Capital Firms.

The ranking is based on fundraising strength in the last five years, investment capacity & the volume and efficiency of exits through IPOs and acquisitions. Thank you!

https://t.co/kIQpY8UKjN

[Catalio Capital Management @CatalioCapital]

Insightful article by @AntoineGara and Oliver Barnes from the @FT over the weekend, highlighting Catalio’s founding story in 2020, our investments (and exits) in innovative healthcare companies, our partnership with @KKR_Co and beyond:

https://t.co/boUKtsirz2

[Catalio Capital Management @CatalioCapital]

We are thrilled that our portfolio company @HaystackMRD⁩ is acquired by ⁦@QuestDX⁩ in an all-cash deal valued at $450M. We co-founded Haystack alongside Dr. Bert Vogelstein & his team, and invested via both our venture & private credit strategies! https://t.co/EGECWLsHxp

[Catalio Capital Management @CatalioCapital]

Great article on today’s ⁦@WSJ⁩ on Catalio’s Structured Opportunities strategy led by John Henry Iucker & Jonathan Blankfein, and the significant opportunity we see in healthcare lending today https://t.co/Gh8KRyyz5Q

[Catalio Capital Management @CatalioCapital]

Today we established the third pillar of our investment platform: a long-short hedge fund investing in global healthcare companies, through the acquisition of HealthCor Management, one of the most successful healthcare hedge funds of the past two decades https://t.co/tiLyUbzY1i

[George Petrocheilos @georgecpetro]

🙏🏼🙏🏼 @sbarnettARK @isaacro

[Isaac Ro @isaacro]

@sbarnettARK Picks and shovels with non-cyclical global demand drivers, non-linear rates of innovation, and inflation+ pricing power. Mostly smidcap stocks making them perpetually underfollowed. One of the best sectors of the economy.

[Catalio Capital Management @CatalioCapital]

We are proud to announce the close of our 3rd VC fund to invest in category-defining life science companies around the globe. With this fund we have grown over 10x since our launch in 2020. Thank you to our investors and teammates for believing in us! https://t.co/zfjewjUhG2

[Catalio Capital Management @CatalioCapital]

Catalio Co-Founder ⁦@georgecpetro⁩ spoke to ⁦@ADeAngelis_bio⁩ ⁦@BusinessInsider⁩ about betting on European biotechs like ⁦@COMPASSPathway⁩ ⁦@DNAScript⁩ & ⁦@atai_life⁩, and the launch of our London office this year! https://t.co/4M8lFz0OOs

[George Petrocheilos @georgecpetro]

Very proud of my dear friend @GTsunis, the new US Ambassador to Greece!

[Greek Reporter @GreekReporter]

George Tsunis Confirmed as U.S. Ambassador to Greece https://t.co/tQbeQv9Hnl

[George Petrocheilos @georgecpetro]

@johncatsjr @JCats2013 @AJ_Cats_ Amazing. Congrats!!!

[George Petrocheilos @georgecpetro]

@geochurch How can Catalio get involved? @geochurch

[Thomas Miller @tfmiller3]

Tremendously exciting news for @entosai to advance our AI-driven drug design platform and open labs/HQ in San Diego.

World-class syndicate including Coatue, @CatalioCapital, @NexusVP, @OrbiMed, and @sequoia.

Entos is hiring in biology, med chem, automation, and AI. Join us!

[Catalio Capital Management @CatalioCapital]

After co-leading @atai_life Series C with @peterthiel & investing in the Series D, we are excited to be part of their successful IPO today (NASDAQ: ATAI) & work with @C_Angermayer, @flobrand & their team in delivering ATAI’s therapeutics to patients with unmet mental health needs

[Catalio Capital Management @CatalioCapital]

Congrats to our portfolio company Singular Genomics (NASDAQ: OMIC) on its successful IPO! We are excited to keep working with @DrewSpaventa and his team to build the future of next generation sequencing technology. @SingularGenomi1

[CNBC Now @CNBCnow]

European Union says Apple’s App Store breaches competition rules https://t.co/Cbe66kW2FY

[George Petrocheilos @georgecpetro]

Very proud of my friend @RecursionChris and the team at our portfolio company @RecursionPharma $RXRX !!

[Chris Gibson @RecursionChris]

I’m excited about the next stage of growth for @RecursionPharma as we become a public company - $RXRX! Our team has worked tirelessly to achieve this milestone and now it is time to put our heads down and get back to work on our mission! Thanks to all who have supported us!

[Catalio Capital Management @CatalioCapital]

It is humbling to make the ⁦@endpts⁩ & ⁦@DealForma list of the top biopharma investors within our first year of operations, alongside industry veterans.⁩ https://t.co/2Yl4pzUtNk https://t.co/2Yl4pzUtNk

[Catalio Capital Management @CatalioCapital]

Today ⁦@ATAI_life⁩ closed its Series D financing, continuing its torrid growth & cementing its reputation as the category-defining business in the mental health therapeutics space. Catalio is proud to have co-led the Series C & participate in the D! https://t.co/IJOX31I3C7